Published 7 July 2009, doi:10.1136/bmj.b2606
Cite this as: BMJ 2009;339:b2606

Analysis

Access to antimalarial therapy: accurate diagnosis is essential to achieving long term goals

Heidi Hopkins, researcher1, Caroline Asiimwe, coordinator for malaria diagnostics implementation1, David Bell, scientist, malaria diagnostics2

1 Foundation for Innovative New Diagnostics (FIND), Kampala, Uganda, 2 World Health Organization—Regional Office for the Western Pacific

Correspondence to: H Hopkins heidi.hopkins@finddiagnostics.org

Increased attention to and funding for malaria promises to improve access to effective treatment, but Heidi Hopkins, Caroline Asiimwe, and David Bell argue that without diagnostic testing much of this effort will be wasted

The first 150 words of the full text of this article appear below.

Health care in malaria endemic areas of Africa is at a crucial tipping point. On the positive side, increased commitment to and funding for malaria control is leading to improved access to effective antimalarial drugs, with over the counter availability and extensive subsidies. However, current efforts do not yet adequately address the need for tools to diagnose malaria accurately and track its incidence. Since presumptive case management leads to dramatic overuse of antimalarial drugs, programmes to improve access will also inevitably lead to further inappropriate treatment for individual patients, increased risk of parasite resistance to antimalarial compounds, and the potential diversion of hundreds of millions of dollars worth of antimalarial drugs to patients who do not actually have malaria. It is vital to make effective antimalarial treatment widely available,1 2 but doing so without equally intensive efforts to improve access to parasite based diagnosis is likely to be counterproductive. Thoughtful implementation . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Subsidise artemisinin for malaria to delay resistance, say analysts
Bob Roehr
BMJ 2009 339: b2908. [Extract] [Full Text]

The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis
Yoel Lubell, Hugh Reyburn, Hilda Mbakilwa, Rose Mwangi, Semkini Chonya, Christopher J M Whitty, and Anne Mills
BMJ 2008 336: 202-205. [Abstract] [Full Text] [PDF]

Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial
Hugh Reyburn, Hilda Mbakilwa, Rose Mwangi, Ombeni Mwerinde, Raimos Olomi, Chris Drakeley, and Christopher J M Whitty
BMJ 2007 334: 403. [Abstract] [Full Text] [PDF]

Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study
Hugh Reyburn, Redepmta Mbatia, Chris Drakeley, Ilona Carneiro, Emmanuel Mwakasungula, Ombeni Mwerinde, Kapalala Saganda, John Shao, Andrew Kitua, Raimos Olomi, Brian M Greenwood, and Christopher J M Whitty
BMJ 2004 329: 1212. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

What, no parasites ?
Oliver R Dearlove
bmj.com, 21 Aug 2009 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ